@wfhemophilia World Congress made one thing clear: The bleeding disorders conversation is still far from equal and it is shaping lives in different ways around the world.
https://t.co/MRz7jBwUqW
Supported through advertising by @SanofiUS#bleedingdisorders#clinicalresearch
Imagine having a treatment plan today and losing access tomorrow. Learn why access is one of the most urgent challenges facing the bleeding disorders community.
https://t.co/MRz7jBwUqW
Supported through advertising by @SanofiUS#bleedingdisorders#clinicalresearch#hematology
The future of bleeding disorders care is being written right now. This episode of the GHR explores what's changing, what's working, and what challenges remain.
https://t.co/MRz7jBwUqW
Supported through advertising by @SanofiUS#bleedingdisorders#clinicalresearch#hematology
Clinicians are debating gene therapy and AI, while families still fight for diagnosis. This week GHR explores what's shaping the future of bleeding disorders care today.
https://t.co/MRz7jBwUqW
Supported through advertising by @SanofiUS#clinicalresearch#hematology
A child with hemophilia B, stuck on bypassing agents and barely able to play—then rebalancing agents changed everything. Hear Dr. Carpenter on the latest episode of GHR.
https://t.co/MRz7jBwUqW
Supported by @sanofi#clinicalresearch#hematology#GHRpod#bloodstreammedia
Too much clotting is dangerous. Too little causes bleeding. On the latest GHR, Dr. Hermans dives into how rebalancing agents strike the delicate middle ground for certain patients.
https://t.co/MRz7jBwUqW
Supported by @sanofi#clinicalresearch#hematology#bloodstreammedia
Dr. Amy Dunn highlights why keeping the community connected is essential—patient and family voices drive government decisions and must be included in every conversation.
https://t.co/MRz7jBwUqW
Supported through advertising by @SanofiUS#bleedingdisorders#clinicalresearch
Dr. Donna DiMichele joins Patrick James Lynch to explore how science, data, and humanity have shaped the story of hemophilia on the latest episode of GHR.
https://t.co/MRz7jBwUqW
Supported through advertising by @sanofi#bleedingdisorders#clinicalresearch#hematology
When researchers and clinicians come together nationally, rare disease studies can build on each other to set new care standards. Dr. Donna DiMichele breaks down this collaborative approach.
https://t.co/MRz7jBwUqW
Supported by @SanofiUS#clinicalresearch#hematology#GHRpod
Maria Santaella from @nbd_foundation explains why including women in studies is critical—and how we can ensure non-HTC clinicians take these findings seriously.
https://t.co/MRz7jBwUqW
Supported through advertising by @SanofiUS#clinicalresearch#hematology#GHRpod